These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6331295)

  • 21. Synergy of fosfomycin with beta-lactam antibiotics against staphylococci and aerobic gram-negative bacilli.
    Chin NX; Neu NM; Neu HC
    Drugs Exp Clin Res; 1986; 12(12):943-7. PubMed ID: 3569007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activity of coumermycin in comparison to other non-beta-lactam antibiotics against staphylococci, streptococci, and Clostridium difficile.
    Mittermayer H
    Chemioterapia; 1987 Jun; 6(2 Suppl):163-4. PubMed ID: 3509379
    [No Abstract]   [Full Text] [Related]  

  • 23. Coumermycin: in vitro activity against 251 clinical isolates of bacteria compared with the activities of eight other antibacterial agents.
    Digranes A; Salveson A; Dibb WL
    Acta Pathol Microbiol Immunol Scand B; 1986 Apr; 94(2):85-8. PubMed ID: 3728027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of LY146032 (daptomycin), a new peptolide.
    Ehlert F; Neu HC
    Eur J Clin Microbiol; 1987 Feb; 6(1):84-90. PubMed ID: 3032611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of Sch 34343 against enterococci and other gram-positive bacteria.
    Eliopoulos GM; Reiszner E; Moellering RC
    Antimicrob Agents Chemother; 1985 Jan; 27(1):28-32. PubMed ID: 3845792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro and in vivo antibacterial activities of T-3262, a new fluoroquinolone.
    Fujimaki K; Noumi T; Saikawa I; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1988 Jun; 32(6):827-33. PubMed ID: 2843082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of LY264826 compared to other glycopeptides and daptomycin.
    Chin NX; Neu HC
    Diagn Microbiol Infect Dis; 1991; 14(2):181-4. PubMed ID: 1651826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity of two new aryl-fluoroquinolone antimicrobial agents, difloxacin (A-56619) and A-56620 compared to that of other antimicrobial agents.
    Hirschhorn L; Neu HC
    Chemotherapy; 1987; 33(1):28-39. PubMed ID: 3549179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 4-Quinolone interactions with gyrase subunit B inhibitors.
    Lewin CS; Howard BM; Smith JT
    J Med Microbiol; 1991 Dec; 35(6):358-62. PubMed ID: 1661337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In-vitro activity of pefloxacin compared to enoxacin, norfloxacin, gentamicin and new beta-lactams.
    Clarke AM; Zemcov SJ; Campbell ME
    J Antimicrob Chemother; 1985 Jan; 15(1):39-44. PubMed ID: 3156112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activities of two oxazolidinone antimicrobial agents, DuP 721 and DuP 105.
    Neu HC; Novelli A; Saha G; Chin NX
    Antimicrob Agents Chemother; 1988 Apr; 32(4):580-3. PubMed ID: 3377467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of dactimicin, a novel pseudodisaccharide aminoglycoside, compared with activities of other aminoglycosides.
    Gu JW; Neu HC
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1998-2003. PubMed ID: 2514625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro interactions of carumonam in combination with coumermycin, teicoplanin, flucloxacillin and vancomycin.
    Machka K; Milatovic D; Braveny I
    Chemioterapia; 1987 Jun; 6(2 Suppl):117-8. PubMed ID: 2978385
    [No Abstract]   [Full Text] [Related]  

  • 34. In vitro activity of Ro 23-6240, a new fluorinated 4-quinolone.
    Chin NX; Brittain DC; Neu HC
    Antimicrob Agents Chemother; 1986 Apr; 29(4):675-80. PubMed ID: 3085584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activity of norfloxacin, a quinolinecarboxylic acid, compared with that of beta-lactams, aminoglycosides, and trimethoprim.
    Neu HC; Labthavikul P
    Antimicrob Agents Chemother; 1982 Jul; 22(1):23-7. PubMed ID: 6214995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of cefodizime (HR-221).
    Ahonkhai VI; Cherubin CE; Shulman MA
    Antimicrob Agents Chemother; 1982 Oct; 22(4):715-8. PubMed ID: 6295264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-vitro activity of enoxacin (CL-919), a new quinoline derivative, compared with that of other antimicrobial agents.
    Wise R; Andrews JM; Danks G
    J Antimicrob Chemother; 1984 Mar; 13(3):237-44. PubMed ID: 6586712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discrepancy between the antibacterial activities and the inhibitory effects on Micrococcus luteus DNA gyrase of 13 quinolones.
    Fu KP; Grace ME; McCloud SJ; Gregory FJ; Hung PP
    Chemotherapy; 1986; 32(6):494-8. PubMed ID: 3026740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cefotetan, a new cephamycin: comparison of in vitro antimicrobial activity with other cephems, beta-lactamase stability, and preliminary recommendations for disk diffusion testing.
    Ayers LW; Jones RN; Barry AL; Thornsberry C; Fuchs PC; Gavan TL; Gerlach EH; Sommers HM
    Antimicrob Agents Chemother; 1982 Nov; 22(5):859-77. PubMed ID: 6983862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibacterial activity of ofloxacin and its mode of action.
    Sato K; Inoue Y; Fujii T; Aoyama H; Mitsuhashi S
    Infection; 1986; 14 Suppl 4():S226-30. PubMed ID: 3028966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.